Cargando…

Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants

BACKGROUND: Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture,...

Descripción completa

Detalles Bibliográficos
Autores principales: Saturno, Maurizio, Stewart, Sharon, Bell, Erin, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671275/
https://www.ncbi.nlm.nih.gov/pubmed/33791613
http://dx.doi.org/10.1093/asjof/ojz018
_version_ 1783610898873581568
author Saturno, Maurizio
Stewart, Sharon
Bell, Erin
Esposito, Emanuela
author_facet Saturno, Maurizio
Stewart, Sharon
Bell, Erin
Esposito, Emanuela
author_sort Saturno, Maurizio
collection PubMed
description BACKGROUND: Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture, and rupture are risks often associated with breast implants. OBJECTIVES: The authors conducted a retrospective study to analyze and report complication rates associated with Eurosilicone’s (Eurosilicone S.A.S, Apt, Cedex, France) silicone gel–filled breast implants over a period of 5 years. METHODS: In this retrospective clinical study, 2151 women who underwent either breast augmentation or breast reconstruction with Eurosilicone breast implants were diagnosed. Data on early and late complications including implant removal (explantation/exchange), capsular contracture, and rupture were collected using questionnaires, completed by 39 surgeons across Italy. RESULTS: Of the 2151, only 60 patients (2.78%) required implant removal. Twenty-five patients experienced capsular contracture (Baker Grade III/IV), giving an actual rate of 1.2%. The actual rate of implant rupture confirmed by breast magnetic resonance images was 0.18% (4 implants). Six patients (0.27%) were diagnosed with breast cancer following breast augmentation, and local complications including hematoma (1 patient) and seroma (2 patients) were experienced. CONCLUSIONS: This retrospective clinical study involving Eurosilicone’s round and anatomical textured silicone gel–filled mammary implants demonstrates an excellent safety profile through 5 years. Level of Evidence: 2 [Image: see text]
format Online
Article
Text
id pubmed-7671275
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76712752021-03-30 Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants Saturno, Maurizio Stewart, Sharon Bell, Erin Esposito, Emanuela Aesthet Surg J Open Forum Original Article BACKGROUND: Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture, and rupture are risks often associated with breast implants. OBJECTIVES: The authors conducted a retrospective study to analyze and report complication rates associated with Eurosilicone’s (Eurosilicone S.A.S, Apt, Cedex, France) silicone gel–filled breast implants over a period of 5 years. METHODS: In this retrospective clinical study, 2151 women who underwent either breast augmentation or breast reconstruction with Eurosilicone breast implants were diagnosed. Data on early and late complications including implant removal (explantation/exchange), capsular contracture, and rupture were collected using questionnaires, completed by 39 surgeons across Italy. RESULTS: Of the 2151, only 60 patients (2.78%) required implant removal. Twenty-five patients experienced capsular contracture (Baker Grade III/IV), giving an actual rate of 1.2%. The actual rate of implant rupture confirmed by breast magnetic resonance images was 0.18% (4 implants). Six patients (0.27%) were diagnosed with breast cancer following breast augmentation, and local complications including hematoma (1 patient) and seroma (2 patients) were experienced. CONCLUSIONS: This retrospective clinical study involving Eurosilicone’s round and anatomical textured silicone gel–filled mammary implants demonstrates an excellent safety profile through 5 years. Level of Evidence: 2 [Image: see text] Oxford University Press 2019-06-20 /pmc/articles/PMC7671275/ /pubmed/33791613 http://dx.doi.org/10.1093/asjof/ojz018 Text en © 2019 The American Society for Aesthetic Plastic Surgery, Inc. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saturno, Maurizio
Stewart, Sharon
Bell, Erin
Esposito, Emanuela
Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
title Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
title_full Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
title_fullStr Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
title_full_unstemmed Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
title_short Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
title_sort five-year retrospective analysis of eurosilicone’s silicone gel–filled breast implants
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671275/
https://www.ncbi.nlm.nih.gov/pubmed/33791613
http://dx.doi.org/10.1093/asjof/ojz018
work_keys_str_mv AT saturnomaurizio fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants
AT stewartsharon fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants
AT bellerin fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants
AT espositoemanuela fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants